When was ZAP-X founded?

ZAP-X was founded in 2014 and raised its 1st funding round 6 years after it was founded.

Where is ZAP-X located?

ZAP-X is headquartered in San Carlos, United States.

How many employees does ZAP-X have?

As of Jun 30, 2026, the latest employee count at ZAP-X is 123.

Is ZAP-X a funded company?

ZAP-X is a funded company, having raised a total of $160M across 2 funding rounds to date. The company's 1st funding round was a $***** Series D round, raised on Jan 08, 2020.

When was the latest funding round of ZAP-X?

ZAP-X's latest funding was a $***** Series E round on Nov 09, 2024, with participation from 1 investor. Its primary sector is Healthcare IT. In United States, the Healthcare IT sector has seen $4.31B in funding in 2026 to date.

Where does ZAP-X rank among its competitors?

ZAP-X ranks 7th amongst 74 active competitors, of which 23 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Perimeter Med, which secured $4M in Apr, 2026.

Who are the top competitors of ZAP-X?

ZAP-X's top competitors include RefleXion, Alpha Tau Medical and TechsoMed. Among them, Perimeter Med secured the most recent funding round in April, 2026.

ZAP-X - 2026 Company Profile, Team, Funding & Competitors

ZAP-X is a series E company based in San Carlos (United States), founded in 2014. It operates as a Developer of gyroscopic radiosurgery platform. ZAP-X has raised $160M in funding from Primavera. The company has 74 active competitors, including 23 funded and 12 that have exited. Its top competitors include companies like RefleXion, Alpha Tau Medical and TechsoMed.

Company Details

Developer of gyroscopic radiosurgery platform. The company's flagship product, ZAP-X platform is a self-shielding technology and non-invasive cancer radiotherapy treatment device. It has applications for the treatment of brain and head and neck cancers.

Website: zapsurgical.com
Social
Email ID: *****@zapsurgical.com

Key Metrics

Founded Year

2014

Location

San Carlos, United States

Stage

Series E

Total Funding

$160M in 2 rounds

Latest Funding Round

Series E, Nov 09, 2024, $*****

Investors

Primavera & 7 more

Ranked

7^th among 74 active competitors

Employee Count

123 as on Jun 30, 2026

Similar Companies

RefleXion & 86 more

View ZAP-X's full profile

ZAP-X has raised a total funding of $160M over 2 rounds. Its first funding round was on Jan 08, 2020. Its latest funding round was a Series E round on Nov 09, 2024 for $*****. 1 investor participated in its latest round. ZAP-X has 8 institutional investors.

Here is the list of recent funding rounds of ZAP-X:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 09, 2024	8699658	Series E	1191018	8619203	8934890	1046245
Jan 08, 2020	6963627	Series D	7176174	5612851	Primavera	GT Healthcare Capital Partners & 5 more

Access funding benchmarks and valuations. Sign up today!

View details of ZAP-X's funding rounds and investors

ZAP-X's employee count trend

ZAP-X has 123 employees as of Jun 26. Here is ZAP-X's employee count trend over the years:

Uncover ZAP-X's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of ZAP-X include RefleXion, Alpha Tau Medical and TechsoMed. Here is the list of Top 10 competitors of ZAP-X, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	RefleXion 2009, Hayward (United States), Series F	Provider of biology-guided radiotherapy system	$542M	The Rise Fund, PSP Investments & 24 others	70/100
2nd	Alpha Tau Medical 2015, Tel Aviv (Israel), Public	Developer of radiotherapy technique for the treatment of solid cancer tumors	$55M	Shavit Capital, OurCrowd & 15 others	66/100
3rd	TechsoMed 2012, Rehovot (Israel), Series B	Developer of ultrasound-based monitoring systems for thermal ablation procedures	$9.6M	Johnson & Johnson Innovation, Axil Capital ... & 19 others	60/100
4th	Mevion Medical Systems 2004, Littleton (United States), Series F	Proton therapy systems for oncology	$500M	ProQuest Investments, Yuan Ming Capital & 9 others	60/100
5th	Perimeter Med 2013, Dallas (United States), Public	Provider of an AI based tissue imaging platform for cancer diagnosis and surgery	$12.3M	Northview LifeSciences, MaRS Discovery District ... & 8 others	59/100
6th	Alpheus Medical 2014, Chanhassen (United States), Series B	Developer of Sonodynamic therapy device for brain cancer	$68M	Orbimed, Samsara BioCapital & 7 others	58/100
7th	ZAP-X 2014, San Carlos (United States), Series E	Developer of gyroscopic radiosurgery platform	$160M	Foxconn Electronics, GT Healthcare Capital Partners ... & 6 others	57/100
8th	OncoRes Medical 2014, Perth (Australia), Series B	Developer of intraoperative imaging technology for surgical procedures	$33.1M	Brandon BioCatalyst, Australian Unity & 5 others	57/100
9th	ABK Biomedical 2012, Halifax (Canada), Series D	Developer of imageable embolic medical devices targeting benign and malignant hypervascular tumors	$140M	F-Prime Capital, Varian Medical Systems & 8 others	55/100
10th	Cel-Sci 1983, Vienna (United States), Public	Developer of immunotherapy products for the treatment of cancer and infectious diseases	-	Alpha Capital Partners, Midsummer Capital ... & 7 others	53/100